Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study

Shuji Ikegami*1)、Masanao Nakamura*1)、Takashi Honda*1)、Takeshi Yamamura*1)、Keiko Maeda *2)、Tsunaki Sawada *2)、Eri Ishikawa*1)、Kenta Yamamoto*1)、Satoshi Furune*1)、Takuya Ishikawa*1)、Kazuhiro Furukawa*1)、Eizaburo Ohno*1)、Masatoshi Ishigami*1)、 Fumie Kinoshita*3)、Yoshihiro Kadota *4)、Takumi Tochio*4)、Yoshiharu Shimomura*5)、Yoshiki Hirooka*6)、Hiroki Kawashima*1) 1)Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine 2)Department of Endoscopy, Nagoya University Graduate School of Medicine 3)Department of Advanced Medicine, Nagoya University Hospital 4)B Food Science Co., Ltd. 5)Department of Food and Nutritional Sciences, College of Bioscience and Biotechnology, Chubu University 6)Department of Liver, Biliary Tract, and Pancreas Diseases, Fujita Health University School of Medicine
Alimentary Pharmacology & Therapeutics